Neurological Soft Signs in Bipolar Disorder in Comparison To Healthy Controls and Schizophrenia: a Meta-Analysis

Loading...
Publication Logo

Date

2018-11

Authors

Akgul, Ozge
Ceylan, Deniz

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Open Access Color

Green Open Access

No

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Top 10%
Influence
Top 10%
Popularity
Top 10%

Research Projects

Journal Issue

Abstract

Neurological soft signs (NSS) are subtle deficits in motor coordination, sensory integration, and sequencing of complex motor acts. Increased NSS is a well-established feature of patients with schizophrenia but a relatively smaller number of studies have investigated NSS in bipolar disorder (BD). Some authors but not others suggested that NSS can distinguish schizophrenia from BD. We conducted a meta-analysis of 18 studies to quantitatively review NSS in BD in comparison to schizophrenia and healthy controls. The current meta-analysis compared NSS scores of 725 BD patients and 634 healthy controls, and 391 BD and 471 schizophrenia patients. Patients with BD had significantly higher NSS scores (d = 1.14, CI = 0.89-1.44) than healthy controls and increased scores in BD was evident in all aspects of NSS (d = 0.88-0.99). BD was associated with a less severe increase in NSS compared to schizophrenia, however, between-group difference was modest (d = 0.42, CI = 0.18-0.65). The results of this meta-analysis demonstrated that BD is characterized by a robust increase in NSS which is only moderately less severe than schizophrenia. Increased NSS is a common feature of both disorders. (c) 2018 Elsevier B.V. and ECNP. All rights reserved.

Description

Keywords

Neurological soft signs, Bipolar disorder, Schizophrenia, Meta-analysis, Systematic review, Cognitive Impairment, Discriminate Schizophrenia, Euthymic Patients, I Disorder, Brain Morphology, Dysfunction, Instrument, Psychosis, Relatives, Bipolar Disorder, Case-Control Studies, Schizophrenia, Diagnostic Techniques, Neurological, Humans, Nervous System Diseases

Fields of Science

03 medical and health sciences, 0302 clinical medicine

Citation

WoS Q

Q1

Scopus Q

Q1
OpenCitations Logo
OpenCitations Citation Count
43

Source

European Neuropsychopharmacology

Volume

28

Issue

11

Start Page

1185

End Page

1193
PlumX Metrics
Citations

CrossRef : 33

Scopus : 41

Captures

Mendeley Readers : 62

SCOPUS™ Citations

42

checked on Apr 28, 2026

Web of Science™ Citations

39

checked on Apr 28, 2026

Page Views

3

checked on Apr 28, 2026

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
2.5999

Sustainable Development Goals

SDG data is not available